Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 6Unknown 5Completed 3Terminated 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Urinary Bladder Neoplasms 1Thymoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1SCLC, Extensive Stage 1Resectable Esophageal Cancer 1Rectal Neoplasms 1Pathologic Complete Response 1Oropharyngeal Neoplasms 1Neoplasms 1NSCLC 1Mouth Neoplasms 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 8Radiotherapy 6Carboplatin 6toripalimab 5pembrolizumab 5Surgical Procedures, Operative 5Nivolumab 5Docetaxel 5Cetuximab 5Paclitaxel 4Drug Therapy 4Taxes 3Specimen Handling 3Magnetic Resonance Spectroscopy 3trilaciclib 2tislelizumab 2nimotuzumab 2camrelizumab 2Radiotherapy, Intensity-Modulated 2Injections 2Cyclophosphamide 2Blood Specimen Collection 2spartalizumab 1penpulimab 1fludarabine phosphate 1fludarabine 1dexamethasone-(C21-phosphoramide)-(anti-EGFR) 1dalpiciclib 1anlotinib 1Tea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Squamous Cell Carcinoma of Head and Neck × Chemoradiotherapy × Clear all
NCT05993858 2023-08-15

PC-1

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Not yet recruiting
33 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡